SCHEMBL20042885

SCHEMBL20042885

Cc1nc2c(c(N3CCC3)n1)C(C)N(C(=O)NC1CC1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP5K1C O60331 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TSHR P16473 4/20 0.32
LMNA P02545 2/20 0.32
NR4A1 P22736 1/20 0.32
IDH1 O75874 1/20 0.32
GAA P10253 3/20 0.32
HSD17B10 Q99714 2/20 0.32
USP2 O75604 2/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
HPGDS O60760 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31614760 0.82 SMN1; SMN2 (0.36) SMN1; SMN2KDM4ETSHRLMNANR4A1
SCHEMBL20042990 0.81 CNR1 (0.37) SMN1; SMN2KDM4EALDH1A1TSHRLMNA
SCHEMBL31614810 0.78 CHRM4 (0.42) PDE4BPDE4D
SCHEMBL20042858 0.77 ALDH1A1 (0.37) SMN1; SMN2KDM4EALDH1A1TSHRLMNA
SCHEMBL31615020 0.77 PDE10A (0.35) SMN1; SMN2KDM4EALDH1A1NPC1TSHR
SCHEMBL20042875 0.77 PDE10A (0.35) SMN1; SMN2KDM4EALDH1A1NPC1TSHR
SCHEMBL31615013 0.77 PDE10A (0.35) SMN1; SMN2KDM4EALDH1A1NPC1TSHR
SCHEMBL31614910 0.77 PDE10A (0.35) SMN1; SMN2KDM4EALDH1A1NPC1TSHR
SCHEMBL20042742 0.76 PROKR1 (0.35) SMN1; SMN2KDM4EALDH1A1HSD17B10MEN1
Hydrochloric Acid SCHEMBL31614990 0.75 PARP1 (0.34) SMN1; SMN2KDM4ETSHRLMNANR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed